Author

Irinel Popescu

Professor of Surgery Fundeni Clinical Institute, Titu Maiorescu University - Cited by 14,117 - organ transplantation - oncology - translational research - robotic surgery

Biography

Popescu studied medicine at Carol Davila University of Medicine and Pharmacy in Bucharest and graduated in 1977.He became a Specialist Surgeon in 1983, and in 1990 he became a General Surgeon, getting a PhD from Carol Davila University Bucharest. In 1997, Popescu, along with a group of other scientists, established Romtransplant, a professional organization for raising awareness of the importance of organs transplantation through several arranged national congresses.He teaches in the Faculty of Medicine of Carol Davila University of Medicine and Pharmacy.
Title
Cited by
Year
Prognostic impact of perineural invasion in intrahepatic cholangiocarcinoma: multicentre study
T Wei, XF Zhang, J He, I Popescu, HP Marques, L Aldrighetti, SK Maithel, ...British Journal of Surgery 10 (7), 610-616, 2022202
9
2022
miRNAs as biomarkers in diabetes: moving towards Precision Medicine
MA Angelescu, O Andronic, SO Dima, I Popescu, I Meivar-Levy, S Ferber, ...International Journal of Molecular Sciences 23 (21), 12843, 2022202
7
2022
The association between TRP channels expression and Clinicopathological characteristics of patients with pancreatic adenocarcinoma
NR Chelaru, A Chiosa, A Sorop, A Spiridon, F Cojocaru, D Domocos, ...International Journal of Molecular Sciences 23 (1), 9045, 2022202
6
2022
Collagen family and other matrix remodeling proteins identified by bioinformatics analysis as hub genes involved in gastric cancer progression and prognosis
M Chivu-Economescu, LG Necula, L Matei, D Dragu, C Bleotu, A Sorop, ...International Journal of Molecular Sciences 23 (), 3214, 2022202
6
2022
A novel online calculator to predict risk of microvascular invasion in the preoperative setting for hepatocellular carcinoma patients undergoing curative-intent surgery
Y Endo, L Alaimo, HA Lima, Z Moazzam, F Ratti, HP Marques, ...Annals of Surgical Oncology 30 (2), 72-733, 2023202
5
2023
A multi-center post-market clinical study to confirm safety and performance of PuraStat® in the management of bleeding during open liver resection
CB Nahm, I Popescu, F Botea, S Fenwick, C Fondevila, I Bilbao, D Reim, ...HPB 24 (), 700-707, 2022202
5
2022
Impact of tumor burden score on timing and patterns of recurrence after curative-intent resection of hepatocellular carcinoma
Z Moazzam, HA Lima, L Alaimo, Y Endo, CF Shaikh, F Ratti, HP Marques, ...Surgery 172 (), 1448-14, 2022202
5
2022
Preoperative risk score (PreopScore) to predict overall survival after resection for hepatocellular carcinoma
Y Endo, HA Lima, L Alaimo, Z Moazzam, Z Brown, CF Shaikh, F Ratti, ...HPB 25 (), 5-62, 20220
3
2023
TAC score better predicts survival than the BCLC following resection of hepatocellular carcinoma
HA Lima, Y Endo, Z Moazzam, L Alaimo, C Shaikh, MM Munir, V Resende, ...Journal of Surgical Oncology 127 (), 74-84, 20220
3
2023
Tumor Burden Score and Serum Alpha-fetoprotein Subclassify Intermediate-Stage Hepatocellular Carcinoma
HA Lima, Y Endo, L Alaimo, Z Moazzam, MM Munir, C Shaikh, V Resende, ...Journal of Gastrointestinal Surgery 26 (12), 2512-2521, 2022202
3
2022
Non-transplantable recurrence after resection for transplantable hepatocellular carcinoma: implication for upfront treatment choice
XF Zhang, F Xue, F Bagante, F Ratti, HP Marques, S Silva, O Soubrane, ...Journal of Gastrointestinal Surgery 6 (5), 101-109, 0
2
2022
TBS-based preoperative score to predict non-transplantable recurrence and identify candidates for upfront resection versus transplantation for hepatocellular carcinoma
HA Lima, Z Moazzam, Y Endo, L Alaimo, C Shaikh, MM Munir, V Resende, ...Annals of Surgical Oncology 30 (6), 3363-3373, 030
2
2023
Characteristics, management, and outcomes of patients with left‐sided infective endocarditis complicated by heart failure: a substudy of the ESC‐EORP EURO‐ENDO (European …
Y Bohbot, G Habib, C Laroche, E Stöhr, C Chirouze, ...European journal of heart failure 4 (7), 153-165, 0
2
2022
Parenchyma-sparing liver resection or regenerative liver surgery: which way to go?
F Botea, A Bârcu, A Kraft, I Popescu, M LineckerMedicina 58 (10), 14, 0
2
2022
Dynamic prediction of survival after curative resection of intrahepatic cholangiocarcinoma: a landmarking-based analysis
G Spolverato, G Capelli, G Lorenzoni, D Gregori, J He, I Popescu, ...Annals of surgical oncology 9 (1), 7634-7641, 0
2
2022
Application of hazard functions to investigate recurrence after curative-intent resection for hepatocellular carcinoma
HA Lima, L Alaimo, ZJ Brown, Y Endo, Z Moazzam, DI Tsilimigras, ...HPB 5 (), 60-68, 030
2
2023
A comprehensive preoperative predictive score for post-hepatectomy liver failure after hepatocellular carcinoma resection based on patient comorbidities, tumor burden, and …
L Alaimo, Y Endo, HA Lima, Z Moazzam, CF Shaikh, A Ruzzenente, ...Journal of Gastrointestinal Surgery 26 (2), 2486-2495, 2022202
1
2022
Comparative RNA-Sequencing Analysis Reveals High Complexity and Heterogeneity of Transcriptomic and Immune Profiles in Hepatocellular Carcinoma Tumors of Viral (HBV, HCV) and …
L Paslaru, G Bindea, A Nastase, A Sorop, C Zimbru, V Herlea, D Hrehoret, ...Medicina 58 (2), 803, 2022202
1
2022
Variations in Textbook Oncologic Outcomes After Curative-Intent Resection: Early Versus Intermediate Hepatocellular Carcinoma Based on Barcelona Clinic Liver Cancer Criteria …
Z Moazzam, L Alaimo, Y Endo, HA Lima, CF Shaikh, F Ratti, HP Marques, ...Annals of Surgical Oncology 30 (2), 750-759, 2023202
1
2023
Machine Learning Model Validated to Predict Outcomes of Liver Transplantation Recipients with Hepatitis C: The Romanian National Transplant Agency Cohort Experience
ML Zabara, I Popescu, A Burlacu, O Geman, RAC Dabija, IV Popa, ...Sensors 23 (4), 249, 2023202
1
2023

Referred From: https://scholar.google.com/citations?user=SLwKIAIAAAAJ&hl=th

Cited by
Citations 14117
h-index 58
i10-index 232
Recommended Journals
Open Access Journals